New Jersey Sues Big Pharma CEO For Illegally Pushing A Deadly Fentanyl Drug

Share:

Officials are in New Jersey are expanding the focus of their lawsuit against a top manufacturer of a fentanyl-based medication to include the company’s CEO.

New Jersey Attorney General Christopher Porrino announced Friday that the state is amending its current consumer fraud and false claims complaint against Insys Therapeutics, an Arizona-based pharmaceutical manufacturer. Porrino is targeting Insys’s billionaire CEO and founder John Kapoor, alleging that he engaged in a scheme involving fraudulent prescriptions of their fentanyl-based drug Subsys that led to the death of a New Jersey resident, reports NJ.com.

Kapoor was arrested in Arizona Oct. 26 on federal charges of conspiracy to commit racketeering, mail fraud and wire fraud, to which he is pleading not guilty. Porrino said in the filing Friday that “we reject the suggestion that he had only a hands-off, observer’s role in the process of illegally expanding the off-label prescription market for his company’s flagship drug Subsys.”

New Jersey sued Insys, which produces a sublingual fentanyl spray, Oct. 5, accusing the company of flagrantly violating the law by aggressively pushing doctors in the state to prescribe the drug at higher doses for conditions for which it was not approved.

[contentcards url=”http://dailycaller.com/2017/11/18/new-jersey-sues-big-pharma-ceo-for-illegally-pushing-a-deadly-fentanyl-drug/” target=”_blank”]
Share:
No Comments Yet

Leave a Reply

2021 © True Pundit. All rights reserved.